Search / Trial NCT02198443

Elvitegravir (Stribild ®). Prospective, Randomized, Open.
Launched by FUNDACION CLINIC PER A LA RECERCA BIOMÉDICA · Jul 22, 2014

Download PDF

Apply for Trial

Trial Information

Current as of April 30, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

Inclusion Criteria:
• Age greater than 18 years
• Have been exposed to HIV, non-occupational and meets the requirements of current recommendations to start with three antiretroviral drugs PEP
• that adequately informed consent in writing to participate in the study and undergo testing and exploration that entails
Exclusion Criteria:
• pregnant women, lactating, or those intend become pregnant during the study period.
• subjects who are known or suspected case presents the source resistors to one of the drugs of the pattern of study
• contraindicated treatment with the study drugs, or products under investigation

About Fundacion Clinic Per A La Recerca Biomédica

Fundació Clinic per a la Recerca Biomèdica is a prominent research foundation affiliated with the Hospital Clinic of Barcelona, dedicated to advancing biomedical research and promoting innovative healthcare solutions. With a strong emphasis on collaboration among scientists, clinicians, and industry partners, the foundation supports a wide range of clinical trials aimed at translating scientific discoveries into effective therapies. Its mission is to enhance patient care through cutting-edge research, fostering an environment of excellence that drives improvements in medical treatments and contributes to the global body of biomedical knowledge.

Locations

Barcelona, , Spain

Patients applied

0 patients applied

Trial Officials

Felipe García, MD

Principal Investigator

Hospital clínic y provincial de Barcelona

Timeline

First submit

July 22, 2014

Trial launched

June 06, 2015

Trial updated

February 20, 2017

Estimated completion

Not reported

Similar Trials